Clinical Trial Update: Daytime Impact Sleep Study [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 daytime impact sleep study for nocturia sponsored by Ferring Pharmaceuticals has been terminated. No results are …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 2 | Status: TERMINATED